California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.


WTO Digital Trade Talks Stall as E-Commerce Tariff Deadline Looms
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
How the war in Iran is already affecting UK farmers and food production
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss 



